DOTmed December 29, 2023
John R. Fischer

Through an appeals court, Apple has hit pause on the International Trade Commission’s ban that bars it from selling Apple Watches containing a disputed blood oxygen sensor allegedly designed with stolen trade secrets.

The ITC proposed the ban in October based on a January 2023 verdict that found Apple guilty of infringing on a patent by Masimo, which accused Apple of stealing multiple patents and its employees to design the light-based pulse oximetry functionality that debuted in 2020 in the company’s Apple Watch Series 6 version.

The ban was scheduled to take effect on Christmas day and was not vetoed by President Joe Biden, who had 60 days to do so. Apple ended sales for the Apple Watch Series 9...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article